All In Biotech

Drug Trial Radar · NCT07341672

A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants

The Drug-Drug Interaction Study of Clifutinib

Last checked: Nov 19, 2026Latest source record: Apr 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruiting

Status

Not yet recruiting

Enrollment

80

Planned (sponsor's estimate)

Start

Dec 31, 2026

Primary completion

Apr 23, 2027

Study completion May 8, 2027

Sponsor

Lead sponsor
Sunshine Lake Pharma Co., Ltd.Industry
Sponsor type
Industry
First posted
Jan 14, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 50 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Evaluate the pharmacokinetic effects of itraconazole, fluconazole, or efavirenz on a single - dose of Clifutinib and the safety of the combination therapy in healthy participants.

Conditions

  • Healthy Adult Subject

Interventions

  • ClifutinibDrug

    The subjects are required to take Clifutinib on an empty stomach for at least 10 hours and without drinking water for 1 hour. After taking the drug, they should fast for 4 hours and refrain from drinking water for 1 hour.

  • ItraconazoleDrug

    Itraconazole is taken orally approximately 30 minutes after the start of breakfast and lunch.

  • fluconazoleDrug

    Take fluconazole on an empty stomach

  • efavirenzDrug

    Take efavirenz on an empty stomach

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. CmaxTime frame: From Day1 to Day50
  2. AUC0-tTime frame: From Day1 to Day50
  3. AUC0-∞Time frame: From Day1 to Day50
  4. %AUCexTime frame: From Day1 to Day50
  5. TmaxTime frame: From Day1 to Day50
  6. t1/2Time frame: From Day1 to Day50

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The First Affiliated Hospital of Shandong First Medical University (Shandong Qianfoshan Hospital)

    Jinan, Shandong, China

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.